Industry Research Reports

Home > Reports > Pharma & Healthcare > Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-02-25

Pages: 85 Pages

Report ld: 4305738

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Alimta was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

North American market for Alimta was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Alimta was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Alimta was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Alimta include Eli Lilly, Abbott Healthcare, Cadila Healthcare, Eagle Pharmaceuticals, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Alimta, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Alimta by region & country, by Type, and by Application.

The Alimta market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alimta.

Market Segmentation

By Company

Eli Lilly
Abbott Healthcare
Cadila Healthcare
Eagle Pharmaceuticals

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

100mg
500mg

Segment by Application

Pleural Mesothelioma
Non-small Cell Lung Cancer

biaoTi Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Alimta manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Alimta in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Alimta in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYResearch's Strengths

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

Table of Contents

1 Market Overview

1.1 Alimta Product Introduction

1.2 Global Alimta Market Size Forecast

1.2.1 Global Alimta Sales Value (2020-2031)

1.2.2 Global Alimta Sales Volume (2020-2031)

1.2.3 Global Alimta Sales Price (2020-2031)

1.3 Alimta Market Trends & Drivers

1.3.1 Alimta Industry Trends

1.3.2 Alimta Market Drivers & Opportunity

1.3.3 Alimta Market Challenges

1.3.4 Alimta Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Alimta Players Revenue Ranking (2024)

2.2 Global Alimta Revenue by Company (2020-2025)

2.3 Global Alimta Players Sales Volume Ranking (2024)

2.4 Global Alimta Sales Volume by Company Players (2020-2025)

2.5 Global Alimta Average Price by Company (2020-2025)

2.6 Key Manufacturers Alimta Manufacturing Base and Headquarters

2.7 Key Manufacturers Alimta Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Alimta

2.9 Alimta Market Competitive Analysis

2.9.1 Alimta Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Alimta Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alimta as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 100mg

3.1.2 500mg

3.2 Global Alimta Sales Value by Type

3.2.1 Global Alimta Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Alimta Sales Value, by Type (2020-2031)

3.2.3 Global Alimta Sales Value, by Type (%) (2020-2031)

3.3 Global Alimta Sales Volume by Type

3.3.1 Global Alimta Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Alimta Sales Volume, by Type (2020-2031)

3.3.3 Global Alimta Sales Volume, by Type (%) (2020-2031)

3.4 Global Alimta Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pleural Mesothelioma

4.1.2 Non-small Cell Lung Cancer

4.2 Global Alimta Sales Value by Application

4.2.1 Global Alimta Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Alimta Sales Value, by Application (2020-2031)

4.2.3 Global Alimta Sales Value, by Application (%) (2020-2031)

4.3 Global Alimta Sales Volume by Application

4.3.1 Global Alimta Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Alimta Sales Volume, by Application (2020-2031)

4.3.3 Global Alimta Sales Volume, by Application (%) (2020-2031)

4.4 Global Alimta Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Alimta Sales Value by Region

5.1.1 Global Alimta Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Alimta Sales Value by Region (2020-2025)

5.1.3 Global Alimta Sales Value by Region (2026-2031)

5.1.4 Global Alimta Sales Value by Region (%), (2020-2031)

5.2 Global Alimta Sales Volume by Region

5.2.1 Global Alimta Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Alimta Sales Volume by Region (2020-2025)

5.2.3 Global Alimta Sales Volume by Region (2026-2031)

5.2.4 Global Alimta Sales Volume by Region (%), (2020-2031)

5.3 Global Alimta Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Alimta Sales Value, 2020-2031

5.4.2 North America Alimta Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Alimta Sales Value, 2020-2031

5.5.2 Europe Alimta Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Alimta Sales Value, 2020-2031

5.6.2 Asia Pacific Alimta Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Alimta Sales Value, 2020-2031

5.7.2 South America Alimta Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Alimta Sales Value, 2020-2031

5.8.2 Middle East & Africa Alimta Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Alimta Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Alimta Sales Value

6.2.1 Key Countries/Regions Alimta Sales Value, 2020-2031

6.2.2 Key Countries/Regions Alimta Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Alimta Sales Value, 2020-2031

6.3.2 United States Alimta Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Alimta Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Alimta Sales Value, 2020-2031

6.4.2 Europe Alimta Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Alimta Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Alimta Sales Value, 2020-2031

6.5.2 China Alimta Sales Value by Type (%), 2024 VS 2031

6.5.3 China Alimta Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Alimta Sales Value, 2020-2031

6.6.2 Japan Alimta Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Alimta Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Alimta Sales Value, 2020-2031

6.7.2 South Korea Alimta Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Alimta Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Alimta Sales Value, 2020-2031

6.8.2 Southeast Asia Alimta Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Alimta Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Alimta Sales Value, 2020-2031

6.9.2 India Alimta Sales Value by Type (%), 2024 VS 2031

6.9.3 India Alimta Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Eli Lilly

7.1.1 Eli Lilly Company Information

7.1.2 Eli Lilly Introduction and Business Overview

7.1.3 Eli Lilly Alimta Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Eli Lilly Alimta Product Offerings

7.1.5 Eli Lilly Recent Development

7.2 Abbott Healthcare

7.2.1 Abbott Healthcare Company Information

7.2.2 Abbott Healthcare Introduction and Business Overview

7.2.3 Abbott Healthcare Alimta Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Abbott Healthcare Alimta Product Offerings

7.2.5 Abbott Healthcare Recent Development

7.3 Cadila Healthcare

7.3.1 Cadila Healthcare Company Information

7.3.2 Cadila Healthcare Introduction and Business Overview

7.3.3 Cadila Healthcare Alimta Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Cadila Healthcare Alimta Product Offerings

7.3.5 Cadila Healthcare Recent Development

7.4 Eagle Pharmaceuticals

7.4.1 Eagle Pharmaceuticals Company Information

7.4.2 Eagle Pharmaceuticals Introduction and Business Overview

7.4.3 Eagle Pharmaceuticals Alimta Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Eagle Pharmaceuticals Alimta Product Offerings

7.4.5 Eagle Pharmaceuticals Recent Development

8 Industry Chain Analysis

8.1 Alimta Industrial Chain

8.2 Alimta Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Alimta Sales Model

8.5.2 Sales Channel

8.5.3 Alimta Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

Table of Figures

List of Tables

Table 1. Alimta Market Trends

Table 2. Alimta Market Drivers & Opportunity

Table 3. Alimta Market Challenges

Table 4. Alimta Market Restraints

Table 5. Global Alimta Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Alimta Revenue Market Share by Company (2020-2025)

Table 7. Global Alimta Sales Volume by Company (2020-2025) & (Kg)

Table 8. Global Alimta Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Alimta Price by Company (2020-2025) & (USD/g)

Table 10. Key Manufacturers Alimta Manufacturing Base and Headquarters

Table 11. Key Manufacturers Alimta Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Alimta

Table 13. Global Alimta Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alimta as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Alimta Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Alimta Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Alimta Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Alimta Sales Market Share in Value by Type (2020-2025)

Table 20. Global Alimta Sales Market Share in Value by Type (2026-2031)

Table 21. Global Alimta Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)

Table 22. Global Alimta Sales Volume by Type (2020-2025) & (Kg)

Table 23. Global Alimta Sales Volume by Type (2026-2031) & (Kg)

Table 24. Global Alimta Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Alimta Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Alimta Price by Type (2020-2025) & (USD/g)

Table 27. Global Alimta Price by Type (2026-2031) & (USD/g)

Table 28. Global Alimta Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Alimta Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Alimta Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Alimta Sales Market Share in Value by Application (2020-2025)

Table 32. Global Alimta Sales Market Share in Value by Application (2026-2031)

Table 33. Global Alimta Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)

Table 34. Global Alimta Sales Volume by Application (2020-2025) & (Kg)

Table 35. Global Alimta Sales Volume by Application (2026-2031) & (Kg)

Table 36. Global Alimta Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Alimta Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Alimta Price by Application (2020-2025) & (USD/g)

Table 39. Global Alimta Price by Application (2026-2031) & (USD/g)

Table 40. Global Alimta Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Alimta Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Alimta Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Alimta Sales Value by Region (2020-2025) & (%)

Table 44. Global Alimta Sales Value by Region (2026-2031) & (%)

Table 45. Global Alimta Sales Volume by Region (Kg): 2020 VS 2024 VS 2031

Table 46. Global Alimta Sales Volume by Region (2020-2025) & (Kg)

Table 47. Global Alimta Sales Volume by Region (2026-2031) & (Kg)

Table 48. Global Alimta Sales Volume by Region (2020-2025) & (%)

Table 49. Global Alimta Sales Volume by Region (2026-2031) & (%)

Table 50. Global Alimta Average Price by Region (2020-2025) & (USD/g)

Table 51. Global Alimta Average Price by Region (2026-2031) & (USD/g)

Table 52. Key Countries/Regions Alimta Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Alimta Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Alimta Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Alimta Sales Volume, (2020-2025) & (Kg)

Table 56. Key Countries/Regions Alimta Sales Volume, (2026-2031) & (Kg)

Table 57. Eli Lilly Company Information

Table 58. Eli Lilly Introduction and Business Overview

Table 59. Eli Lilly Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 60. Eli Lilly Alimta Product Offerings

Table 61. Eli Lilly Recent Development

Table 62. Abbott Healthcare Company Information

Table 63. Abbott Healthcare Introduction and Business Overview

Table 64. Abbott Healthcare Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 65. Abbott Healthcare Alimta Product Offerings

Table 66. Abbott Healthcare Recent Development

Table 67. Cadila Healthcare Company Information

Table 68. Cadila Healthcare Introduction and Business Overview

Table 69. Cadila Healthcare Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 70. Cadila Healthcare Alimta Product Offerings

Table 71. Cadila Healthcare Recent Development

Table 72. Eagle Pharmaceuticals Company Information

Table 73. Eagle Pharmaceuticals Introduction and Business Overview

Table 74. Eagle Pharmaceuticals Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 75. Eagle Pharmaceuticals Alimta Product Offerings

Table 76. Eagle Pharmaceuticals Recent Development

Table 77. Key Raw Materials Lists

Table 78. Raw Materials Key Suppliers Lists

Table 79. Alimta Downstream Customers

Table 80. Alimta Distributors List

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Alimta Product Picture

Figure 2. Global Alimta Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Alimta Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Alimta Sales Volume (2020-2031) & (Kg)

Figure 5. Global Alimta Sales Price (2020-2031) & (USD/g)

Figure 6. Alimta Report Years Considered

Figure 7. Global Alimta Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Alimta Players Sales Volume Ranking (2024) & (Kg)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Alimta Revenue in 2024

Figure 10. Alimta Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. 100mg Picture

Figure 12. 500mg Picture

Figure 13. Global Alimta Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Alimta Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Alimta Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)

Figure 16. Global Alimta Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Alimta Price by Type (2020-2031) & (USD/g)

Figure 18. Product Picture of Pleural Mesothelioma

Figure 19. Product Picture of Non-small Cell Lung Cancer

Figure 20. Global Alimta Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 21. Global Alimta Sales Value Market Share by Application, 2024 & 2031

Figure 22. Global Alimta Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)

Figure 23. Global Alimta Sales Volume Market Share by Application, 2024 & 2031

Figure 24. Global Alimta Price by Application (2020-2031) & (USD/g)

Figure 25. North America Alimta Sales Value (2020-2031) & (US$ Million)

Figure 26. North America Alimta Sales Value by Country (%), 2024 VS 2031

Figure 27. Europe Alimta Sales Value, (2020-2031) & (US$ Million)

Figure 28. Europe Alimta Sales Value by Country (%), 2024 VS 2031

Figure 29. Asia Pacific Alimta Sales Value, (2020-2031) & (US$ Million)

Figure 30. Asia Pacific Alimta Sales Value by Region (%), 2024 VS 2031

Figure 31. South America Alimta Sales Value, (2020-2031) & (US$ Million)

Figure 32. South America Alimta Sales Value by Country (%), 2024 VS 2031

Figure 33. Middle East & Africa Alimta Sales Value, (2020-2031) & (US$ Million)

Figure 34. Middle East & Africa Alimta Sales Value by Country (%), 2024 VS 2031

Figure 35. Key Countries/Regions Alimta Sales Value (%), (2020-2031)

Figure 36. Key Countries/Regions Alimta Sales Volume (%), (2020-2031)

Figure 37. United States Alimta Sales Value, (2020-2031) & (US$ Million)

Figure 38. United States Alimta Sales Value by Type (%), 2024 VS 2031

Figure 39. United States Alimta Sales Value by Application (%), 2024 VS 2031

Figure 40. Europe Alimta Sales Value, (2020-2031) & (US$ Million)

Figure 41. Europe Alimta Sales Value by Type (%), 2024 VS 2031

Figure 42. Europe Alimta Sales Value by Application (%), 2024 VS 2031

Figure 43. China Alimta Sales Value, (2020-2031) & (US$ Million)

Figure 44. China Alimta Sales Value by Type (%), 2024 VS 2031

Figure 45. China Alimta Sales Value by Application (%), 2024 VS 2031

Figure 46. Japan Alimta Sales Value, (2020-2031) & (US$ Million)

Figure 47. Japan Alimta Sales Value by Type (%), 2024 VS 2031

Figure 48. Japan Alimta Sales Value by Application (%), 2024 VS 2031

Figure 49. South Korea Alimta Sales Value, (2020-2031) & (US$ Million)

Figure 50. South Korea Alimta Sales Value by Type (%), 2024 VS 2031

Figure 51. South Korea Alimta Sales Value by Application (%), 2024 VS 2031

Figure 52. Southeast Asia Alimta Sales Value, (2020-2031) & (US$ Million)

Figure 53. Southeast Asia Alimta Sales Value by Type (%), 2024 VS 2031

Figure 54. Southeast Asia Alimta Sales Value by Application (%), 2024 VS 2031

Figure 55. India Alimta Sales Value, (2020-2031) & (US$ Million)

Figure 56. India Alimta Sales Value by Type (%), 2024 VS 2031

Figure 57. India Alimta Sales Value by Application (%), 2024 VS 2031

Figure 58. Alimta Industrial Chain

Figure 59. Alimta Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

Related Reports

Global Alimta Market Research Report 2024
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published Date: 2024-01-04
Pages: 74
USD 2900.00
(Single User License)
Alimta - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published Date: 2024-01-24
Pages: 85
USD 3950.00
(Single User License)
Global Alimta Market Insights, Forecast to 2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published Date: 2024-04-15
Pages: 76
USD 4900.00
(Single User License)
Global Alimta Market Research Report 2025
The global market for Alimta was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 69
USD 2900.00
(Single User License)
Global Alimta Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Alimta market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 71
USD 4250.00
(Single User License)
Global Alimta Market Research Report 2026
The global Alimta market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 97
USD 2900.00
(Single User License)
Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Alimta was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 122
USD 3950.00
(Single User License)

Global Alimta Market Research Report 2024
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published: 2024-01-04
Pages: 74
USD 2900.00 (Single User License)
Alimta - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published: 2024-01-24
Pages: 85
USD 3950.00 (Single User License)
Global Alimta Market Insights, Forecast to 2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published: 2024-04-15
Pages: 76
USD 4900.00 (Single User License)
Global Alimta Market Research Report 2025
The global market for Alimta was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 69
USD 2900.00 (Single User License)
Global Alimta Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Alimta market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 71
USD 4250.00 (Single User License)
Global Alimta Market Research Report 2026
The global Alimta market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 97
USD 2900.00 (Single User License)
Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Alimta was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 122
USD 3950.00 (Single User License)